Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123272) titled 'Individualized Dose Optimization Strategy of Efsubaglutide Guided by Millimeter-Wave Radar Non-Contact Monitoring for Treatment' on April 23.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai General Hospital
Condition:
Obstructive Sleep Apnea
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: Observation group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=317554
Published by HT Digital Content Services with permission from Health Daily Digest....